Investigation of Pancreaticoduodenectomy

March 1, 2020 updated by: Chen Xiaoping, Tongji Hospital

A Multicenter Big⁃Sample Retrospective Study of Pancreaticoduodenectomy

The investigators intend to conduct a multicentre, big-sample, retrospective study to analysis the surgery results of pancreaticoduodenectomy and compare the different suture technique.

Study Overview

Status

Completed

Detailed Description

For patients with malignant or benign disease of the pancreatic head and periampullary region, pancreaticoduodenectomy is the only potential approach to radical cure. However, pancreaticoduodenectomy is consider as one of the most complex operations associated with a high rate of postoperative complications such as pancreatic fistula, delayed gastric emptying, hemorrhage, abscess, and sepsis. These complications increase the costs associated with pancreaticoduodenectomy. Numerous interventions and techniques have been introduced to decrease the morbidity. But there is little evidence for the superiority of one anastomotic technique over the others. Therefore, investigators intend to conduct a multicentre, big-sample, retrospective study to analysis the surgery results of pancreaticoduodenectomy and compare the different suture technique.

Study Type

Observational

Enrollment (Actual)

10085

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hubei
      • Wuhan, Hubei, China, 430030
        • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who had underwent pancreaticoduodenectomy between 2008 to 2018.

Description

Inclusion Criteria:

Patients who had underwent pancreaticoduodenectomy between 2008 to 2018.

Exclusion Criteria:

None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
pancreaticoduodenectomy
patients underwent pancreaticoduodenectomy in recent ten years.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of Postoperative Pancreatic Fistula(POPF)
Time Frame: Within 30 days after surgery
The frequency of POPF occurs and the POPF will be strictly diagnosis and classified according to IGSPF criteria.
Within 30 days after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of operation
Time Frame: Intraoperative
The time of operation count by minute.
Intraoperative
Mortality
Time Frame: Within 30 days after surgery
The death occurred within 30 days after surgery
Within 30 days after surgery
Length of hospital stay after surgery
Time Frame: From first day after surgery to release from hospital (anticipate 5 days minimally)
Days between surgery and hospital discharge
From first day after surgery to release from hospital (anticipate 5 days minimally)
Morbidity
Time Frame: Within 90 days after surgery
The incidence of operative complications within 90 days after surgery
Within 90 days after surgery
Hospital costs
Time Frame: From first day after surgery to release from hospital (anticipate 5 days minimally)
The total hospitalization expenses
From first day after surgery to release from hospital (anticipate 5 days minimally)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2019

Primary Completion (Actual)

August 1, 2019

Study Completion (Actual)

August 1, 2019

Study Registration Dates

First Submitted

December 21, 2018

First Submitted That Met QC Criteria

December 28, 2018

First Posted (Actual)

January 2, 2019

Study Record Updates

Last Update Posted (Actual)

March 4, 2020

Last Update Submitted That Met QC Criteria

March 1, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • C201812

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pancreaticoduodenectomy

Subscribe